title: Primary Cutaneous Cryptococcus in a Patient With Multiple Sclerosis Treated With Fingolimod.
authors.affiliation: Department of Dermatology, University of Pennsylvania, Philadelphia.
authors.forename: Amy K
authors.initials: AK
authors.lastname: Forrestel
authors.affiliation: Department of Dermatology, University of Pennsylvania, Philadelphia.
authors.forename: Badri G
authors.initials: BG
authors.lastname: Modi
authors.affiliation: Division of Infectious Diseases, University of Pennsylvania, Philadelphia.
authors.forename: Sarah
authors.initials: S
authors.lastname: Longworth
authors.affiliation: Division of Infectious Diseases, University of Pennsylvania, Philadelphia.
authors.forename: Marissa B
authors.initials: MB
authors.lastname: Wilck
authors.affiliation: Department of Dermatology, University of Pennsylvania, Philadelphia.
authors.forename: Robert G
authors.initials: RG
authors.lastname: Micheletti
mesh_terms: D003453:Cryptococcosis / Q000175:diagnosis* / Q000188:drug therapy; D003455:Cryptococcus neoformans / Q000302:isolation & purification / Q000472:pathogenicity*; D005260:Female; D000068876:Fingolimod Hydrochloride / Q000009:adverse effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy*; D014946:Wound Infection / Q000175:diagnosis* / Q000188:drug therapy
chemical_list: D007166:Immunosuppressive Agents; D000068876:Fingolimod Hydrochloride